4.5 Article

First-in-human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children

Palang Chotsiri et al.

NATURE COMMUNICATIONS (2019)

Review Obstetrics & Gynecology

A systematic review and meta-analysis of dihydroartemisinin-piperaquine versus sulphadoxine-pyrimethamine for malaria prevention in pregnancy

Atinuke Olaleye et al.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2019)

Editorial Material Pharmacology & Pharmacy

Safety Assessment of Acyl Glucuronides-A Simplified Paradigm

Dennis A. Smith et al.

DRUG METABOLISM AND DISPOSITION (2018)

Review Infectious Diseases

Experimental infection of human volunteers

Meta Roestenberg et al.

LANCET INFECTIOUS DISEASES (2018)

Review Infectious Diseases

New developments in anti-malarial target candidate and product profiles

Jeremy N. Burrows et al.

MALARIA JOURNAL (2017)

Article Pharmacology & Pharmacy

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview

Stephen P. H. Alexander et al.

BRITISH JOURNAL OF PHARMACOLOGY (2017)

Article Biochemistry & Molecular Biology

Origins of the specificity of inhibitor P218 toward wild-type and mutant PfDHFR: a molecular dynamics analysis

Sheenu Abbat et al.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2015)

Article Multidisciplinary Sciences

Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target

Yongyuth Yuthavong et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Public, Environmental & Occupational Health

Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda

SG Staedke et al.

TROPICAL MEDICINE & INTERNATIONAL HEALTH (2004)

Article Public, Environmental & Occupational Health

Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure?

SA Omar et al.

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2001)